Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation

P Matzinger. Tolerance, danger, and the extended familyAnnu Rev Immunol. 1994.

J Banchereau, R Steinman. Dendritic cells and the control of immunityNature. 1998.

N Janikashvili, N Larmonier, E Katsanis. Personalized dendritic cell-based tumor immunotherapyImmunotherapy. 2010.

A Sexton, P G Whitney, S F Chong. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsulesACS Nano. 2009.

H P Feng, Y Zeng, M W Graner, A Likhacheva, E Katsanis. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunityBlood. 2003.

A Zabaleta, D Llopiz, L Arribillaga. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 proteinMol Ther. 2008.

D Boczkowski, S K Nair, J H Nam, H K Lyerly, E Gilboa. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cellsCancer Res. 2000.

J C Steele, A Rao, J R Marsden. Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaGene Ther. 2011.

A Bolhassani, S Safaiyan, S Rafati. Improvement of different vaccine delivery systems for cancer therapyMol Cancer. 2011.

B Weide, C Garbe, H G Rammensee, S Pascolo. Plasmid DNA-and messenger RNAbased anti-cancer vaccinationImmunol Lett. 2008.

I A Khalil, K Kogure, H Akita, H Harashima. Uptake pathways and subsequent intracellular trafficking in nonviral gene deliveryPharmacol Rev. 2006.

A Heit, D H Busch, H Wagner, F Schmitz. Vaccine protocols for enhanced immunogenicity of exogenous antigensInt J Med Microbiol. 2008.

J A Hubbell, S N Thomas, M A Swartz. Materials engineering for immunomodulationNature. 2009.

O A Ali, N Huebsch, L Cao, G Dranoff, D J Mooney. Infection-mimicking materials to program dendritic cells in situNat Mater. 2009.

O A Ali, D J Mooney. Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cellsJ Control Release. 2008.

S Mukherjee, R N Ghosh, Maxfield Fr Endocytosis. Physiol Rev. 1997.

C D Platt, J K Ma, C Chalouni, M Ebersold, H Bou-Reslan, Rad Carano, I Mellman, L Delamarre. Mature dendritic cells use endocytic receptors to capture and present antigensProc Natl Acad Sci U S A. 2010.

X F Zhou, B Liu, X H Yu. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccineJ Control Release. 2007.

K Birkholz, M Schwenkert, C Kellner. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentationBlood. 2010.

A Bandyopadhyay, R L Fine, S Demento, L K Bockenstedt, T M Fahmy. The impact of nanoparticle ligand density on dendritic-cell targeted vaccinesBiomaterials. 2011.

P J Tacken, De Vries, Ijm Torensma, R Figdor, C G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNat Rev Immunol. 2007.

M Baggiolini. Chemokines and leukocyte trafficNature. 1998.

S R Mccoll. Chemokines and dendritic cells: a crucial allianceImmunol Cell Biol. 2002.

M C Dieu, B Vanbervliet, A Vicari. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sitesJ Exp Med. 1998.

M Foti, F Granucci, D Aggujaro. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory siteInt Immunol. 1999.

S A Kellermann, S Hudak, E R Oldham, Y J Liu, L M Mcevoy. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro-and in vivo-derived dendritic cellsJ Immunol. 1999.

A N Stachowiak, Y Wang, Y C Huang, D J Irvine. Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesisJ Immunol. 2006.

A Dimberg. Chemokines in angiogenesisCurr Top Microbiol. 2010.

H E Broxmeyer. Chemokines in hematopoiesisCurr Opin Hematol. 2008.

M F Bachmann, M Kopf, B J Marsland. Chemokines: more than just road signsNat Rev Immunol. 2006.

B J Marsland, P Battig, M Bauer. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cellsImmunity. 2005.

M Swamy, C Jamora, W Havran, A Hayday. Epithelial decision makers: in search of the 'epimmunome'Nat Immunol. 2010.

B Pulendran, H Tang, S Manicassamy. Programming dendritic cells to induce T H 2 and tolerogenic responsesNat Immunol. 2010.

L Piemonti, P Monti, P Allavena, B E Leone, A Caputo, Di Carlo, V. Glucocorticoids increase the endocytic activity of human dendritic cellsInt Immunol. 1999.

J A Clingan, Y Yanagawa, K Iwabuchi, K Onoe. Effect of T helper 1 (Th1)/Th2 cytokine on chemokine-induced dendritic cell functionsCell Immunol. 2006.

Y Yanagawa, K Onoe. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activitiesBlood. 2003.

Y Yanagawa, K Onoe. CCR7 ligands induce endocytosis and the formation of actinfilled ruffles in mature dendritic cellsJ Clin Exp Hematop. 2005.

M R Koller, J G Bender, E T Papoutsakis, W M Miller. Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitorsBlood. 1992.

Kla Souza, M Elsner, Pcf Mathias, S Lenzen, M Tiedge. Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cellsDiabetologia. 2004.

A Hot, V Lenief, P Miossec. Combination of IL-17 and TNF a induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cellsAnn Rheum Dis. 2012.

M B Lutz, N Kukutsch, Alj Ogilvie, S Rossner, F Koch, N Romani, G Schuler. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowJ Immunol Methods. 1999.

M B Lutz, R M Suri, M Niimi, A L Ogilvie, N A Kukutsch, S Rossner, G Schuler, J M Austyn. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivoEur J Immunol. 2000.

P Yu, S Xiong, Q He, Y Chu, C Lu, C A Ramlogan, J C Steel. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allograftsImmunology. 2009.

N Kotzor, M Lechmann, E Zinser, A Steinkasserer. The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cellsImmunobiology. 2004.

J Imai, H Hasegawa, M Maruya, S Koyasu, I Yahara. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cellsInt Immunol. 2005.

J Oura, Y Tamura, K Kamiguchi, G Kutomi, H Sahara, T Torigoe, T Himi, N Sato. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cellsInt Immunol. 2011.

F Sallusto, M Cella, C Danieli, A Lanzavecchia. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class-II compartment -down-regulation by cytokines and bacterial productsJ Exp Med. 1995.

J Hauser, M Ellisman, H U Steinau, Stefan E Dudda, M Hauser, M. Ultrasound enhanced endocytotic activity of human fibroblastsUltrasound Med Biol. 2009.

K Kikuchi, Y Yanagawa, K Onoe. CCR7 ligand-enhanced phagocytosis of various antigens in mature dendritic cells -time course and antigen distribution different from phagocytosis in immature dendritic cellsMicrobiol Immunol. 2005.

A Z Zallone, A Teti, M V Primavera, L Naldini, P C Marchisio. Osteoclasts and monocytes have similar cytoskeletal structures and adhesion property in vitroJ Anat. 1983.

M A West, A R Prescott, K M Chan, Z J Zhou, S Rose-John, J Scheller, C Watts. TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependentJ Cell Biol. 2008.

C Gawden-Bone, Z J Zhou, E King, A Prescott, C Watts, J Lucocq. Dendritic cell podosomes are protrusive and invade the extracellular matrix using metalloproteinase MMP-14J Cell Sci. 2010.

M A West, Rpa Wallin, S P Matthews, H G Svensson, R Zaru, H G Ljunggren, A R Prescott, C Watts. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodelingScience. 2004.

C Nobile, M Lind, F Miro. Cognate CD4 + T-cell-dendritic cell interactions induce migration of immature dendritic cells through dissolution of their podosomesBlood. 2008.

Djg Mackay, A Hall, Rho Gtpases. J Biol Chem. 1998.

W S Garrett, L M Chen, R Kroschewski, M Ebersold, S Turley, S Trombetta, J E Galan, I Mellman. Developmental control of endocytosis in dendritic cells by Cdc42Cell. 2000.

Y Yanagawa, K Onoe. CCL19 induces rapid dendritic extension of murine dendritic cellsBlood. 2002.

F Sallusto, A Lanzavecchia. Efficient presentation of soluble-antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor-necrosis-factor-aJ Exp Med. 1994.

M Menges, S Rossner, C Voigtlander. Repetitive injections of dendritic cells matured with tumor necrosis factor a induce antigen-specific protection of mice from autoimmunityJ Exp Med. 2002.

C Q Xia, R H Peng, M Annamalai, Clare-Salzler Mj. Dendritic cells post-maturation are reprogrammed with heightened IFN-c and IL-10Biochem Biophys Res Commun. 2007.

J Geisel, F Kahl, M Muller, H Wagner, C J Kirschning, I B Autenrieth, J S Frick. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cellsJ Immunol. 2007.

S Rulle, Mda Kioon, C Asensio, J Mussard, H K Ea, M C Boissier, F Liote, G Falgarone. Adrenomedullin, a neuropeptide with immunoregulatory properties induces semimature tolerogenic dendritic cellsImmunology. 2012.

C E Sutton, S J Lalor, C M Sweeney, C F Brereton, E C Lavelle, Khg Mills. Interleukin-1 and IL-23 induce innate IL-17 production from cd T cells, amplifying Th17 responses and autoimmunityImmunity. 2009.

X Jiang, C Shen, J Rey-Ladino, H Yu, R C Brunham. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunityInfect Immun. 2008.

A W Yewdall, S B Drutman, F Jinwala, K S Bahjat, N Bhardwaj. CD8 + T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cellsPLoS ONE. 2010.

N H Cho, T C Cheong, J H Min. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapyNat Nanotechnol. 2011.

A Martin-Fontecha, S Sebastiani, U E Hopken, M Uguccioni, M Lipp, A Lanzavecchia, F Sallusto. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and primingJ Exp Med. 2003.

N S Wilson, D El-Sukkari, G T Belz, C M Smith, R J Steptoe, W R Heath, K Shortman, J A Villadangos. Most lymphoid organ dendritic cell types are phenotypically and functionally immatureBlood. 2003.

Chemokines in angiogenesis.

Chemokines: more than just road signs.

Epithelial decision makers: in search of the ‘epimmunome.

Glucocorticoids increase the endocytic activity of human dendritic cell.

CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities.

Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors.

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.

Improvement of different vaccine delivery systems for cancer therapy.

Plasmid DNA- and messenger RNAbased anti-cancer vaccination.

Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.

Materials engineering for immunomodulation.

Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cells.

Vaccine protocols for enhanced immunogenicity of exogenous antigens.

Infection-mimicking materials to program dendritic cells in situ.

Endocytosis.

Mature dendritic cells use endocytic receptors to capture and present antigens.

Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine.

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.

The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.

Tolerance, danger and the extended family.

Dendritic cells and the control of immunity.

Personalized dendritic cell-based tumor immunotherapy.

<p>A protective vaccine delivery system for <em>in vivo</em> T cell stimulation using nanoengineered polymer hydrogel capsules</p>.

Mature dendritic cells use endocytic receptors to capture and present antigens.

The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cell.

Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity.

Chemokines and leukocyte traffic.

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.

Chemokines and dendritic cells: a crucial alliance.

Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Combination of IL-17 and TNF a induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells.

Vaccine protocols for enhanced immunogenicity of exogenous antigens.

<p>Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites</p>.

Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site.

Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesis.

Chemokines in hematopoiesis.

CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cell.

Programming dendritic cells to induce TH2 and tolerogenic responses.

Effect of T helper 1 (Th1)/Th2 cytokine on chemokine-induced dendritic cell functions.

CCR7 ligands induce endocytosis and the formation of actinfilled ruffles in mature dendritic cells.

Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype.

<p>Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation</p>.